4 10, 2022 Cytokines and lipid mediators of inflammation in lungs of SARS-CoV-2 infected mice Neal Evan Caminsky2022-11-15T09:14:07-05:00October 4, 2022|Funded Research Results, Pillar 3|
30 09, 2022 A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS -CoV-2 infection Neal Evan Caminsky2022-11-15T09:14:05-05:00September 30, 2022|Funded Research Results, Pillar 3|
27 09, 2022 Human coronaviruses disassemble processing bodies Neal Evan Caminsky2022-11-15T09:14:02-05:00September 27, 2022|Funded Research Results, Pillar 3|
26 09, 2022 Monovalent and trivalent VSV-based COVID-19 vaccines elicit potent neutralizing antibodies and immunodominant CD8+ T cells against diverse SARS-CoV-2 variants Neal Evan Caminsky2022-11-15T09:14:00-05:00September 26, 2022|Funded Research Results, Pillar 3|
9 08, 2022 Zoonotic Characteristics of mpox: Living Evidence Profile Neal Evan Caminsky2023-01-18T15:47:06-05:00August 9, 2022|Funded Research Results, Pillar 9|
26 07, 2022 The Hunan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic Neal Evan Caminsky2022-11-15T09:12:21-05:00July 26, 2022|Funded Research Results, Pillar 2|
7 07, 2022 Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases Neal Evan Caminsky2022-11-15T09:12:18-05:00July 7, 2022|Funded Research Results, Pillar 4|
9 06, 2022 COVID-19 Vaccination and Public Health Countermeasures on Variants of Concern in Canada: Evidence From a Spatial Hierarchical Cluster Analysis Neal Evan Caminsky2022-11-15T09:12:12-05:00June 9, 2022|Funded Research Results, Pillar 8|
27 04, 2022 COVID-19 Vaccination Rollout: Nova Scotia Neal Evan Caminsky2022-11-15T09:12:07-05:00April 27, 2022|Funded Research Results, Pillar 8|
7 04, 2022 COVID-19 Vaccination Rollout: British Columbia Neal Evan Caminsky2022-11-15T09:12:03-05:00April 7, 2022|Funded Research Results, Pillar 8|
